EODData

MEMBERSHIP REGISTER LOG IN

NASDAQ, DNLI: Denali Therapeutics Inc

11 Feb 26 17:38
LAST:

19.69

CHANGE:
 0.13		OPEN:
19.91		HIGH:
20.00		ASK:
0.00		VOLUME:
1.46M
CHG(%):
0.66		PREV:
19.82		LOW:
18.66		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
11 Feb 2619.9120.0018.6619.691.46M
10 Feb 2621.0521.1519.7419.822.0M
09 Feb 2621.2021.2020.1620.841.25M
06 Feb 2620.4021.3120.3621.081.65M
05 Feb 2621.1621.4819.7620.021.63M
04 Feb 2621.9821.9820.6421.281.83M
03 Feb 2622.8923.7721.3221.781.73M
02 Feb 2621.3322.7821.1322.741.59M
30 Jan 2621.3722.0021.1321.742.75M
29 Jan 2621.3621.9920.6721.591.5M

PROFILE

Name:Denali Therapeutics Inc
About:Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutics to treat neurodegenerative and lysosomal storage diseases. The company develops Eclitasertib (SAR443122/DNL758) RIPK1 inhibitor program for peripheral inflammatory diseases; DNL343 eIF2B activator program for amyotrophic lateral sclerosis; BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; TAK-594/DNL593 program for frontotemporal dementia-granulin; DNL126 program for MPS IIIA (Sanfilippo Syndrome A); and DNL310 Tividenofusp alfa, an enzyme replacement therapy program for MPS II (Hunter Syndrome). Its Enzyme TransportVehicle (TV) programs include DNL952 for the treatment of Pompe disease; DNL111 for Parkinson's and Gaucher diseases; and DNL622 for Hurler syndrome (MPS I). The company's OTV programs also comprise DNL628 targeting tau for Alzheimer's disease; and DNL422 targeting alpha synuclein for Parkinson's disease, as well as antibody TV program includes DNL921 targeting Abeta for treating Alzheimer's disease. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.
Sector:Healthcare
Industry:Biotechnology
Address:161 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Website:https://www.denalitherapeutics.com
CUSIP:24823R105
CIK:0001714899
ISIN:US24823R1059
FIGI:BBG008P7F869
LEI:549300ZTQ2HO18L3Q830

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-5.98 
Forward P/E:-5.70 
PEG Ratio:-0.27 
Price to Sales:3,643.65 
Price to Book:2.68 
Return on Assets:-0.25 
Return on Equity:-0.40 
EPS Ratio:-2.92 
Shares:156.16M 
Market Cap:3.075B 

TECHNICAL INDICATORS

MA5:20.293.0%
MA10:21.066.9%
MA20:20.283.0%
MA50:18.645.6%
MA100:17.3213.7%
MA200:15.8624.1%
RSI14:43.23
WPR14:-100.00 
MTM14:-0.56
ROC14:-0.03 
ATR:1.41 
Week High:21.9811.6%
Week Low:18.665.5%
Month High:23.7720.7%
Month Low:16.9624.1%
Year High:23.7720.7%
Year Low:10.5786.3%
Volatility:18.47